James Collins

James Collins has extensive experience in the biotechnology industry, particularly in the field of manufacturing and CMC. At Myeloid Therapeutics from September 2020 to March 2023, James served as Sr Manager, CMC and previously as Manufacturing Manager. Prior to this role, James worked at bluebird bio from May 2015 to September 2020, beginning as a Manufacturing Specialist and later advancing to Associate Scientist. James holds a Bachelor of Science degree in Chemical Engineering from Tufts University, awarded in 2014.